Ozempic
Indian Drug Manufacturers Launch Affordable Alternatives to Ozempic and Wegovy
Indian drug manufacturers are introducing affordable alternatives to Ozempic and Wegovy, aiming to enhance access to obesity treatment worldwide.
Indian Pharmaceutical Firms Launch Affordable Alternatives to Ozempic and Wegovy
Indian drugmakers are launching cheaper versions of Ozempic and Wegovy, enhancing treatment accessibility for diabetes and obesity management.
Indian Drugmakers Launch Affordable Alternatives to Ozempic and Wegovy
Indian pharmaceutical companies are launching affordable alternatives to Novo Nordisk’s Ozempic and Wegovy, expanding access to weight-loss medications.
Pharmaceutical Stocks Surge as Ozempic Ingredient Patent Expires
Pharmaceutical stocks have surged up to 4% as Ozempic’s key ingredient patent expires, paving the way for generics and transforming obesity treatment.
Ozempic Patent Expiry Sparks Weight-Loss Drug Surge in India
The expiry of Ozempic’s patent is set to revolutionize weight-loss drug availability in India, enabling more affordable options for patients.